{"symbol":"BSX","fiscalQuarter":"Q4-2022","reportDate":"2023-02-01","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2022","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 2.79%","keyNumbers":[{"metric":"EPS","actual":"$0.45","expected":"N/A","surprise":"-4.46%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation and product development.","They expressed confidence in long-term growth despite current challenges."],"summary":"Overall, management remains focused on strategic initiatives to drive future growth. They acknowledged some headwinds but emphasized their commitment to innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 2.79%, likely due to management's focus on long-term growth and innovation. The absence of guidance may leave some investors uncertain about future performance, but the overall tone from management was cautiously optimistic.","metaDescription":"Boston Scientific (BSX) Q4 2022 earnings: EPS missed expectations. Stock up 2.79%. Full breakdown."}}